• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经肌肉接头处的自身免疫性离子通道病

Autoimmune Channelopathies at Neuromuscular Junction.

作者信息

Huang Kun, Luo Yue-Bei, Yang Huan

机构信息

Neurology Department, Xiangya Hospital, Central South University, Changsha, China.

Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

Front Neurol. 2019 May 17;10:516. doi: 10.3389/fneur.2019.00516. eCollection 2019.

DOI:10.3389/fneur.2019.00516
PMID:31156543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6533877/
Abstract

The neuromuscular junction, also called myoneural junction, is a site of chemical communication between a nerve fiber and a muscle cell. There are many types of channels at neuromuscular junction that play indispensable roles in neuromuscular signal transmission, such as voltage-gated calcium channels and voltage-gated potassium channels on presynaptic membrane, and acetylcholine receptors on post-synaptic membrane. Over the last two decades, our understanding of the role that autoantibodies play in neuromuscular junction disorders has been greatly improved. Antibodies against these channels cause a heterogeneous group of diseases, such as Lambert-Eaton syndrome, Isaacs' syndrome and myasthenia gravis. Lambert-Eaton syndrome is characterized by late onset of fatigue, skeletal muscle weakness, and autonomic symptoms. Patients with Isaacs' syndrome demonstrate muscle cramps and fasciculation. Myasthenia gravis is the most common autoimmune neuromuscular junction channelopathy characterized by fluctuation of muscle weakness. All these disorders have a high risk of tumor. Although these channelopathies share some common features, they differ for clinical features, antibodies profile, neurophysiological features, and treatments. The purpose of this review is to give a comprehensive insight on recent advances in autoimmune channelopathies at the neuromuscular junction.

摘要

神经肌肉接头,也称为肌神经接头,是神经纤维与肌肉细胞之间进行化学通讯的部位。神经肌肉接头上存在多种类型的通道,它们在神经肌肉信号传递中发挥着不可或缺的作用,例如突触前膜上的电压门控钙通道和电压门控钾通道,以及突触后膜上的乙酰胆碱受体。在过去的二十年里,我们对自身抗体在神经肌肉接头疾病中所起作用的理解有了很大的提高。针对这些通道的抗体可引发一系列不同的疾病,如兰伯特-伊顿综合征、艾萨克斯综合征和重症肌无力。兰伯特-伊顿综合征的特征是疲劳出现较晚、骨骼肌无力和自主神经症状。艾萨克斯综合征患者表现为肌肉痉挛和肌束震颤。重症肌无力是最常见的自身免疫性神经肌肉接头通道病,其特征是肌无力波动。所有这些疾病都有很高的肿瘤风险。尽管这些通道病有一些共同特征,但它们在临床特征、抗体谱、神经生理特征和治疗方法上存在差异。这篇综述的目的是全面深入地了解神经肌肉接头自身免疫性通道病的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b857/6533877/d0b74ce8fa44/fneur-10-00516-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b857/6533877/93b95bfc89b1/fneur-10-00516-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b857/6533877/d0b74ce8fa44/fneur-10-00516-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b857/6533877/93b95bfc89b1/fneur-10-00516-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b857/6533877/d0b74ce8fa44/fneur-10-00516-g0002.jpg

相似文献

1
Autoimmune Channelopathies at Neuromuscular Junction.神经肌肉接头处的自身免疫性离子通道病
Front Neurol. 2019 May 17;10:516. doi: 10.3389/fneur.2019.00516. eCollection 2019.
2
Autoantibodies to ion channels at the neuromuscular junction.针对神经肌肉接头处离子通道的自身抗体。
Autoimmun Rev. 2003 Mar;2(2):94-100. doi: 10.1016/s1568-9972(02)00146-5.
3
[Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].[神经肌肉传递障碍的免疫学方面。2. 实验性自身免疫性重症肌无力和兰伯特-伊顿肌无力综合征]
Lijec Vjesn. 1994 May-Jun;116(5-6):158-61.
4
Neuromuscular junction disorders.神经肌肉接头疾病
Handb Clin Neurol. 2016;133:447-66. doi: 10.1016/B978-0-444-63432-0.00024-4.
5
Autoimmune disorders of neuromuscular transmission.神经肌肉传递的自身免疫性疾病
Semin Neurol. 2008 Apr;28(2):212-27. doi: 10.1055/s-2008-1062260.
6
Autoimmune disorders of the neuromuscular junction.神经肌肉接头自身免疫性疾病
Neurol India. 2008 Jul-Sep;56(3):305-13. doi: 10.4103/0028-3886.43449.
7
Presynaptic Paraneoplastic Disorders of the Neuromuscular Junction: An Update.神经肌肉接头的突触前副肿瘤性疾病:最新进展
Brain Sci. 2021 Aug 3;11(8):1035. doi: 10.3390/brainsci11081035.
8
ANTIBODIES AND RECEPTORS: From Neuromuscular Junction to Central Nervous System.抗体与受体:从神经肌肉接头到中枢神经系统
Neuroscience. 2020 Jul 15;439:48-61. doi: 10.1016/j.neuroscience.2020.03.009. Epub 2020 Mar 17.
9
Immunology of disorders of neuromuscular transmission.神经肌肉传递障碍的免疫学
Acta Neurol Scand Suppl. 2006;183:1-7. doi: 10.1111/j.1600-0404.2006.00605.x.
10
[Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].[兰伯特-伊顿肌无力综合征中针对突触前P/Q型电压门控钙通道的自身抗体]
Brain Nerve. 2013 Apr;65(4):441-8.

引用本文的文献

1
Polymorphism in Glu-Phe-Asp Proteinoids.谷氨酰胺-苯丙氨酸-天冬氨酸类蛋白质的多态性
Biomimetics (Basel). 2025 Jun 3;10(6):360. doi: 10.3390/biomimetics10060360.
2
Case report: Recurring potassium channel complex autoimmunity-related neuropathic pain.病例报告:复发性钾通道复合物自身免疫相关性神经病理性疼痛。
Front Immunol. 2024 Oct 25;15:1390171. doi: 10.3389/fimmu.2024.1390171. eCollection 2024.
3
An update on malignant tumor-related stiff person syndrome spectrum disorders: clinical mechanism, treatment, and outcomes.恶性肿瘤相关僵人综合征谱系障碍的最新进展:临床机制、治疗及预后

本文引用的文献

1
Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis.依氟鸟氨酸改善肌肉特异性激酶重症肌无力小鼠模型的肌肉无力。
Exp Neurol. 2019 Jul;317:133-143. doi: 10.1016/j.expneurol.2019.03.001. Epub 2019 Mar 6.
2
Effectiveness and safety of tacrolimus therapy for myasthenia gravis: A single arm meta-analysis.他克莫司治疗重症肌无力的有效性和安全性:单臂荟萃分析。
J Clin Neurosci. 2019 May;63:160-167. doi: 10.1016/j.jocn.2019.02.004. Epub 2019 Mar 1.
3
Immunosuppressive and monoclonal antibody treatment for myasthenia gravis: A network meta-analysis.
Front Neurol. 2023 Oct 4;14:1209302. doi: 10.3389/fneur.2023.1209302. eCollection 2023.
4
Spotted fever rickettsia-induced microvascular endothelial barrier dysfunction is delayed by the calcium channel blocker benidipine.斑点热立克次体诱导的微血管内皮屏障功能障碍被钙通道阻滞剂苯地平延迟。
Biochem Biophys Res Commun. 2023 Jun 30;663:96-103. doi: 10.1016/j.bbrc.2023.04.045. Epub 2023 Apr 24.
5
Pharmacological Treatments for Congenital Myasthenic Syndromes Caused by Mutations.先天性肌营养不良症致药物治疗突变。
Curr Neuropharmacol. 2023;21(7):1594-1605. doi: 10.2174/1570159X21666230126145652.
6
Myasthenia gravis that has developed long after radical resection of lung cancer: A case report.肺癌根治术后长期发生的重症肌无力:一例报告。
Exp Ther Med. 2022 Jul 5;24(3):554. doi: 10.3892/etm.2022.11492. eCollection 2022 Sep.
7
Clinicopathological-genetic features of congenital myasthenic syndrome from a Chinese neuromuscular centre.中国神经肌肉中心先天性肌无力综合征的临床病理遗传学特征。
J Cell Mol Med. 2022 Jul;26(14):3828-3836. doi: 10.1111/jcmm.17417. Epub 2022 Jun 6.
8
Isaacs' syndrome as the initial presentation of malignant thymoma and associated with double-positive voltage-gated potassium channel complex antibodies, a case report.以 Isaacs 综合征为首发表现的恶性胸腺瘤并伴有双阳性电压门控钾通道复合物抗体:一例报告
BMC Neurol. 2022 Mar 4;22(1):74. doi: 10.1186/s12883-022-02584-7.
9
Controlling ion channel function with renewable recombinant antibodies.利用可再生重组抗体控制离子通道功能。
J Physiol. 2022 May;600(9):2023-2036. doi: 10.1113/JP282403. Epub 2022 Mar 17.
10
A Systematic Review and Meta-Analysis of the Prevalence of Congenital Myopathy.先天性肌病患病率的系统评价与荟萃分析
Front Neurol. 2021 Nov 2;12:761636. doi: 10.3389/fneur.2021.761636. eCollection 2021.
免疫抑制和单克隆抗体治疗重症肌无力:网状荟萃分析。
CNS Neurosci Ther. 2019 May;25(5):647-658. doi: 10.1111/cns.13110. Epub 2019 Feb 26.
4
Who will benefit from thymectomy for myasthenia gravis? Is there any role for this procedure in elderly patients?重症肌无力患者行胸腺切除术后谁将获益?该手术在老年患者中是否有作用?
Ann Transl Med. 2019 Jan;7(1):4. doi: 10.21037/atm.2018.11.66.
5
Italian recommendations for the diagnosis and treatment of myasthenia gravis.意大利关于重症肌无力的诊断和治疗建议。
Neurol Sci. 2019 Jun;40(6):1111-1124. doi: 10.1007/s10072-019-03746-1. Epub 2019 Feb 18.
6
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.依库珠单抗治疗全身性重症肌无力的长期安全性和有效性。
Muscle Nerve. 2019 Jul;60(1):14-24. doi: 10.1002/mus.26447. Epub 2019 Mar 8.
7
Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity.胸腺瘤型重症肌无力:与 HLA-DQB1*05:01 的新关联及高临床和血清学严重程度的有力证据。
J Neurol. 2019 Apr;266(4):982-989. doi: 10.1007/s00415-019-09225-z. Epub 2019 Feb 11.
8
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.非胸腺瘤性重症肌无力患者胸腺切除术联合泼尼松与单纯泼尼松治疗的长期疗效:MGX 随机试验的 2 年延伸。
Lancet Neurol. 2019 Mar;18(3):259-268. doi: 10.1016/S1474-4422(18)30392-2. Epub 2019 Jan 25.
9
Low specificity of voltage-gated calcium channel antibodies in Lambert-Eaton myasthenic syndrome: a call for caution.电压门控钙通道抗体在 Lambert-Eaton 肌无力综合征中的特异性低:需谨慎。
J Neurol. 2018 Sep;265(9):2114-2119. doi: 10.1007/s00415-018-8959-8. Epub 2018 Jul 9.
10
Diagnosis of Myasthenia Gravis.重症肌无力的诊断
Neurol Clin. 2018 May;36(2):261-274. doi: 10.1016/j.ncl.2018.01.010.